Biopharmaceutical plants derive the ideas for developing efficient medicines from pharmaceutical Engineering. They mainly apply the concepts of new and emerging technology that is biotechnology. Some of the living organisms' such as plant sources are great source of raw-materials used to prepare effective medicines. These plants mainly deal with the botanical sources.
The demand for therapeutic proteins is increasing day by day as they have the potential to cure the most lethal diseases. Biotechnology has undergone rapid growth since its introduction about some two decades ago and is still thriving. A huge profit has been obtained from the growth hormones, red-blood-cell stimulating agents, insulin etc. The recombinant proteins can cure arthritis, multiple sclerosis and various orphan diseases. These restorative proteins have become a boon for the mankind.
About 80 biopharmaceutical plants are already in the world market and about 500 are under their development stages at different clinical levels. Among all the biopharmaceuticals present today, recombinant antibodies (rAbs) and their derivatives are the most important. Advancements in biotechnology have enabled the development human antibodies, with improved therapeutic potential. Therapeutic monoclonal antibodies (Mabs) also have enormous potential it contributes to around 40% of the total production of the biopharmaceuticals. These biopharmaceuticals have the ability to fight with the most deadly disease that is cancer.
Biopharmaceutical plants have unlimited potential for efficient drug production. These medicines are both efficient in fighting with diseases as well as cost-effective. Thus, these plants have earned a lot of clinical success in a very short span of time.
About this Author
For more information on Pharmaceutical engineering and the benefits of Biopharmaceutical plants please visit the mentioned website
Article Source: http://EzineArticles.com/?expert=Anjali_Goswami
